Search
for

    Sort by

    Research 181–210 of 1000+

    1. Testosterone Deficiency is Not Protective Against the Development of Adenocarcinoma of the Prostate in a Type 1 Diabetic Patient Diabetes Therapy · 2022
    2. Phytochemicals With Anti 5-alpha-reductase Activity: A Prospective For Prostate Cancer Treatment F1000Research · 2021
    3. 5α-reductase type 3 expression in human benign and malignant tissues: A comparative analysis during prostate cancer progression 2020
    4. EFFECT OF A COMBINATION OF DUTASTERIDE AND PARENTERAL TESTOSTERONE UNDECANOATE ON TESTOSTERONE DEFICIENCY SYMPTOMS AND PROSTATE IN PATIENTS WITH TESTOSTERONE DEFICIENCY AND BENIGN PROSTATIC HYPERPLASIA Journal of Men s Health · 2020
    5. PD35-08 ASSOCIATION OF COMMON MEDICATION WITH PROSTATE-SPECIFIC ANTIGEN LEVEL IN 45-YEAR-OLD GERMAN MEN: RESULTS OF THE PROBASE TRIAL The Journal of Urology · 2019
    6. Association of common medication with prostate-specific antigen level in 45-year-old German men: Results of the PROBASE trial European Urology Supplements · 2019
    7. Additional file 4: of Possible association between androgenic alopecia and risk of prostate cancer and testicular germ cell tumor: a systematic review and meta-analysis Figshare · 2018
    8. Alopecia androgenética masculina de inicio precoz asociada a cáncer de próstata 2017
    9. Alopecia androgenética masculina de inicio precoz asociada a cáncer de próstata 2017
    10. Lower prostate cancer risk in Swedish men with the androgen receptor E213 A-allele Cancer Causes & Control · 2017
    11. The Relationship between Androgenic Alopecia and Prostate Cancer International Journal of Medical Research and Health Sciences · 2016
    12. Effects of the use of finasteride on prostate volume and serum PSA in young patients Digital Library of Theses and Dissertations (Universidade de São Paulo) · 2015
    13. Implicações da toma crónica da Finasteride para a Alopécia Androgenética no Carcinoma da Próstata 2015
    14. Prostate cancer risk and recurrence: the role of nutrition and clinical aspects 2013
    15. Why are men with premature alopecia at higher risk of benign prostatic hyperplasia? And what about prostate cancer? Expert Review of Dermatology · 2012
    16. 343 RELATIONSHIP OF DIETARY INTAKE OF OMEGA-3 AND OMEGA-6 FATTY ACIDS WITH RISK OF PROSTATE CANCER DEVELOPMENT A META-ANALYSIS OF PROSPECTIVE STUDIES AND REVIEW OF LITERATURE The Journal of Urology · 2012
    17. 1451 THE ASSOCIATION BETWEEN MALE PATTERN BALDNESS AND SECOND TO FORTH FINGER RATIO WITH PROSTATE CANCER- A PROSPECTIVE COHORT STUDY The Journal of Urology · 2012
    18. 1449 PROSTATE CANCER PATIENTS WITH METABOLIC SYNDROME SHOWED LOW GRADE GLEASON SCORE WHEN DIAGNOSED ON BIOPSY The Journal of Urology · 2012
    19. Male pattern baldness linked to prostate problems Dermatology Times E-News · 2012
    20. Prostate cancer and androgenic alopecia Expert Review of Endocrinology & Metabolism · 2012
    21. Hair loss at 20 associated with prostate cancer risk later in life Cancer · 2011
    22. 411 THE POTENTIAL OF CIRCULATING ENDOTHELIAL CELLS AS PROGNOSTIC BIOMARKERS IN PROSTATE CANCER European Urology Supplements · 2011
    23. 410 NON-INVASIVE DIAGNOSIS OF PROSTATE CANCER FROM BODY FLUIDS USING A PANEL OF TUMOR SUPPRESSOR GENES European Urology Supplements · 2011
    24. Total prostate volume as risk factor for semen pathologies in ageing male Journal of Men's Health · 2010
    25. S1 OPIOID RECEPTOR AGONISTS AND SERUM PROSTATE SPECIFIC ANTIGENE LEVEL: IS THERE A ROLE FOR PROSTATE CANCER CONTROL AND CHEMOPREVENTION? European Urology Supplements · 2010
    26. S5 IS THE RADICAL PROSTATECTOMY THE BEST CHOICE FOR PATIENTS WITH LOCALLY ADVANCED PROSTATE CANCER? European Urology Supplements · 2010
    27. 1408 INDUCTION OF SECRETED WNT FACTOR WISP1/CCN4 BY HUMAN PROSTATE STROMAL CELLS BY MICROENVIORNMENTAL HYPOXIA The Journal of Urology · 2010
    28. 1406 DETECTION OF MEMBRANE ANDROGEN-BINDING SITE IN LIVING RAT PROSTATE AND EVALUATION OF ITS ROLE IN PROSTATE BLOOD FLOW REGULATION The Journal of Urology · 2010
    29. S89 Clinical outcomes of high risk prostate adenocarcinoma (T3 and Gleason score ≥8) European Urology Supplements · 2009
    30. Urological Oncology: Prostate Cancer The Journal of Urology · 2008